State health insurance regulators expect that the fate of key health insurance subsidies will remain in limbo past key deadlines next month. » Read More
By: Sarah Kliff
More Americans think the government has an obligation to ensure health care coverage to all citizens, Vox reports. » Read More
Glenview Capital Management, Tenet Healthcare's largest shareholder, is pulling its two representatives off the hospital company's board. » Read More
By: Dan Mangan
The settlement came after an unusual lawsuit by Sanofi, a competitor to Mylan, which alleged anti-competitive tactics. » Read More
Wisconsin Sen. Johnson suggested McCain's brain tumor and after-midnight timing affected his vote against the health care bill.
Large companies expect costs to rise by 5 percent (again) in 2018.
One tech company emerged the clear winner.
Nurses and home-care aides at Libertana Home Health Care have been experimenting by using Alexa with some elderly clients.
Venture capitalist Jonathan Silverstein is using his problem-solving skills to find a cure for Parkinson's.
Venture capitalist Jonathan Silverstein, who has been diagnosed with Parkinson's, says it's time to rethink how we approach rare diseases.
Jim Cramer takes a look at what news of Disney’s new exclusive over the top offering could signal for the broader market.
President Donald Trump on Tuesday warned North Korea about facing "fire and fury" if it makes more threats to the U.S.
Shkreli is listed as CEO, while Ralph Holzmann, previously a senior engineer at Twitter, is chief technology officer.
American insurers are quick to cover opioids for pain. Japanese and European insurers are far more hesitant, Vox reports.
The biotech company's drug pamrevlumab successfully completed a mid-stage Food and Drug Administration test.
Valeant cut its full-year revenue forecast, even as it reported a better-than-expected quarterly profit.
Medical geneticists say this is a "very good use" for AI.
Those in the room say the conversation between Epic CEO Judy Faulkner and former Vice President Joe Biden was fairly cordial.
U.S. health insurer Anthem will no longer offer Obamacare plans in Nevada's state exchange, the state's insurance commissioner said Monday.
In Australia, sea creatures that began eating a teenager's legs were identified as "sea fleas," Newsweek reports.
At least during the Obamacare repeal fight in Congress, Sanders was a team player, Vox reports.
Jefferies' research team shared its favorite biotech stock picks with the most interesting near-term catalysts.
Some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics, ProPublica reports.
Emmaus Medical CEO Dr. Yutaka Niihara spent much of his career developing Endari, a recently approved FDA drug to treat sickle cell anemia.
Get the best of CNBC in your inbox